Inovio Pharmaceuticals Delivers Strong Earnings Performance in Latest Report
Wednesday, 6 March 2024, 21:12
Inovio Pharmaceuticals Financial Report
In the latest financial report, Inovio Pharmaceuticals surpassed expectations with a GAAP EPS of -$1.10, exceeding estimates by $0.14. The company also achieved a revenue of $103 million, showcasing strong performance in the pharmaceutical sector.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.